An “urgent preliminary report of Yellow Card data” issued by the UK-based Evidence-Based Medicine Consultancy Ltd submitted to the Medicines and Healthcare Products Regulatory Agency (MHRA) states that “the MHRA now has more than enough evidence on the Yellow Card system to declare the COVID-19 vaccines unsafe for use in humans.”
Similar to the U.S. Vaccine Adverse Events Reporting System (VAERS), the MHRA describes the purpose of its Yellow Card system as providing “an early warning that the safety of a medicine or a medical device may require further investigation.”
The report, signed by Evidence-based Medicine Consultancy Ltd and EbMC Squared CiC Director Dr. Tess Lawrie (MBBCh, PhD), says: “we have searched the Yellow Card reports using pathology-specific key words to group the data according to the following five [sic] broad, clinically relevant categories:
- Bleeding, Clotting and Ischaemic ADRs
- Immune System ADRs
- ‘Pain’ ADRs
- Neurological ADRs
- ADRs involving loss of Sight, Hearing, Speech or Smell
- Pregnancy ADRs”
The report goes on to say: “We are aware of the limitations of pharmacovigilance data and understand that information on reported Adverse Drug Reactions should not be interpreted as meaning that the medicine in question generally causes the observed effect or is unsafe to use. We are sharing this preliminary report due to the urgent need to communicate information that should lead to cessation of the vaccination roll out while a full investigation is conducted. According to the recent paper by Seneff and Nigh, potential acute and long-term pathologies include:
- Pathogenic priming, multisystem inflammatory disease and autoimmunity
- Allergic reactions and anaphylaxis
- Antibody dependent enhancement
- Activation of latent viral infections
- Neurodegeneration and prion diseases
- Emergence of novel variants of SARSCoV2
- Integration of the spike protein gene into the human DNA
“It is now apparent that these products in the blood stream are toxic to humans. An immediate halt to the vaccination programme is required whilst a full and independent safety analysis is undertaken to investigate the full extent of the harms, which the UK Yellow Card data suggest include thromboembolism, multisystem inflammatory disease, immune suppression, autoimmunity and anaphylaxis, as well as Antibody Dependent Enhancement (ADE).”
The report concludes: “The MHRA now has more than enough evidence on the Yellow Card system to declare the COVID-19 vaccines unsafe for use in humans. Preparation should be made to scale up humanitarian efforts to assist those harmed by the COVID-19 vaccines and to anticipate and ameliorate medium to longer term effects. As the mechanism for harms from the vaccines appears to be similar to COVID-19 itself, this includes engaging with numerous international doctors and scientists with expertise in successfully treating COVID-19.
“There are at least 3 urgent questions that need to be answered by the MHRA:
- How many people have died within 28 days of vaccination?
- How many people have been hospitalised within 28 days of vaccination?
- How many people have been disabled by the vaccination?”